The Indian drug regulator CDSCO (Central Drug Standard Control Organization) is all set to be revamped to a world class drug regulator. Inspired by the US FDA, India is making its drug regulator more efficient and of high quality. The CDSCO also might receive a new name “Central Drug Administration” if the proposal was put into practice. An official informed, “The proposal is likely to be taken by the cabinet in two weeks”. READ ALSO: Labeling requirements for registration of medical devices.
After revamping, the Central Drug Administration (CDA) is directly to come under Ministry of Health which is a major development. Currently, CDSCO is under the control of DHGS. The overhaul process also includes massive man power expansion in 2015 – 2025. The current status of 561 employees is to be increased to 1800 which is almost three times of the current manpower. This will make sure the regulations are hassle free considering the US FDA has alerted that there will be increase in imports to the country. READ ALSO: How to register your medical device in India?. Drugs, Cosmetics, Medical Devices, Laboratories, New Emerging Areas and Ayush are all included as the verticals of CDA (Central Drug Administration), the new regulatory body. The Health Ministry is taking different steps to increase the funds and has proposed a revision in fees after 13 years for drug import, registration and licensing to make it profitable. The draft gives the budget of RS 1729 crores for the revamp process by 2015.
Other News
CDSCO Issues Guidelines on Medical Device License Retention
New Delhi, May 15, 2024 — The Central Drugs Standard Control Organization (CDSCO) has released a circular (F. No. MED-15/35/2024-eOffice) on the retention of medical device licenses and certificates under the Medical Devices Rules, 2017. […]
Read More
India Medical Device Pricing Strategy: Ensuring Growth & Affordability
India’s National Pharmaceutical Pricing Authority (NPPA) is developing a specialized India medical device pricing strategy for medical devices, transitioning away from the conventional drug-centric framework. This innovative strategy will incorporate international pricing tactics tailored to […]
Read MoreImports of High-Value Medical Equipment
High-Value Medical Equipment The Central Drugs Standard Control Organization (CDSCO) and the Central Board of Indirect Taxes & Customs have released a new circular, “F.No.401/40/2021-Cus.III,” detailing updated policies on the import of used high-end medical […]
Read MoreSEC Committee: Pioneering Medical Approvals
New important article released by Central Drugs Standard Control Organization (CDSCO) titled “SEC – Special Expert Committee, Medical Devices”. Key highlights include the streamlined processes for CDSCO application evaluations, preparation and significance of briefing materials, […]
Read More
ErlySign Oral Cancer Detection Technology Gets CDSCO Nod
ErlySign, a Nagpur-based biotech startup, has received approval from the Central Drugs Standard Control Organization (CDSCO) to conduct large-scale clinical trials for its novel oral cancer detection technology. The approval for ErlySign follows a rigorous […]
Read MoreAdditional Steps Announced by FDA to Modernize Clinical Trials
The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]
Read MoreAccreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA
This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]
Read MoreBSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing
BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]
Read More
